Table of Content

Introduction to All Panel

Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer. Leukemia, also known as blood cancer, occurs due to abnormal growth and mutation of the WBCs. Bones have spongy tissue called bone marrow, and blood cells form in the bone marrow; in lymphoblastic leukemia, these cells become myeloid or lymphoid cells. 

Lymphoid stem cells become lymphoblast cells, then lymphocytes or white blood cells. The function of the lymphocytes is to create antibodies that help fight the infection. ALL can result in these cells growing out of control. The mutation usually occurs in bone marrow and peripheral blood as well. The Acute Lymphoblastic Leukemia (ALL) Panel helps to identify the leukemic cells by PCR. Consult with your doctor and take the Acute Lymphoblastic Leukemia (ALL) Panel test to confirm the leukemia and start the treatment in the early stages. You can book your test with Redcliffe Labs. The professionals will guide you through the complete Acute Lymphoblastic Leukemia (ALL) Panel test process and provide accurate test reports on time. 

Test details in brief:

Purpose of the ALL Panel test

An Acute Lymphoblastic Leukemia (ALL) panel is a set of laboratory tests and diagnostic procedures designed to detect acute lymphoblastic leukemia. The purpose of the ALL panel is to:

• Diagnose the presence of ALL by examining abnormal blood cells and bone marrow. It causes rapid growth of immature lymphocytes, which impacts the growth of normal production of blood cells. 
• The ALL panel by PCR helps to determine the subtype of acute lymphoblastic leukemia. Different subtypes are classified based on the affected type of lymphocytes (B-cells or T-cells) and the characteristics of the leukemia cells.
• The test helps monitor disease progression. ALL panels may include repeated testing to evaluate the effectiveness of chemotherapy or other treatments.

The ALL panel test by PCR includes a Complete blood count (CBC), bone marrow biopsy, immunophenotyping, cytogenetic analysis, and molecular testing. 

Preparation for the Acute Lymphoblastic Leukemia (ALL) Panel 

The ALL panel does not require any special preparation. You need to follow some simple guidelines before the test. 

• Always consult with your healthcare provider before taking the ALL panel test. Discuss your health and inform you if you take any medications or supplements.
• Fasting is not necessary before the ALL panel. You can eat and drink normally. 
• Don't get stressed, and be calm.
• Avoid taking excess caffeine, alcohol, or smoking before the test.

The procedure of the Acute Lymphoblastic Leukemia (ALL) Panel

The lab expert will collect the blood sample during the Acute lymphoblastic leukemia panel procedure. The sample contains DNA, which is further used for PCR analysis. The phlebotomist will collect the sample from the vein of the arm. The lab expert will first clean the site with an antiseptic solution and then use a needle to collect the sample. You might feel little pain or discomfort during the sample collection. After sample collection, he will put a cotton gauze over the puncture site to stop the blood flow. After some time, they will place a bandage over it. The test results will be available within a few days of the test. 

What do the ALL Panel reports indicate?

The Acute Lymphoblastic Leukemia (ALL) panel test reports confirm the condition of ALL through diagnostic findings. If the test reports show a positive result, it indicates Acute Lymphoblastic Leukemia. The leukemia cells multiply and develop lymphoid T, Lymphoid B, and Myeloid and Monocytic cells. However, the negative results show normal health conditions. 

What does the ALL panel measure?

Various factors are associated with the Acute Lymphoblastic Leukemia (ALL) Panel. The ALL panel measures:

• The ALL panel discusses the specific types of WBCs involved in leukemia.
• Evaluates the chromosomal and molecular abnormalities in leukemia cells.
• It helps to determine the markers on leukemia cells for classification.
• The panel examines the structure and chromosomes in leukemia cells.
• Analyze the genetic mutations associated with Acute Lymphoblastic Leukemia.

By examining these factors, the ALL Panel provides a comprehensive understanding of ALL for accurate diagnosis and treatment decisions.

When do your doctors recommend the ALL panel?

Your doctor may advise the Acute Lymphoblastic Leukemia (ALL) panel test based on your medical history, symptoms, and initial diagnostic assessments. Here are some common scenarios in which an ALL-panel test is recommended-

• If you are experiencing symptoms like fatigue, bruising, abnormal blood count, or infections.
• If your blood count is abnormal in normal blood tests like CBC, your healthcare provider may recommend further testing ALL panels to know the underlying cause.
• The healthcare provider recommends an ALL panel to confirm the condition and whether you have leukemia.

Who should take the Acute Lymphoblastic Leukemia (ALL) Panel?

In most cases, researchers are unsure about the genetic mutations, but ALL is not inherited. Furthermore, certain people are at risk of ALL, including:

• People who have siblings, like twins, with ALL
• People with Genetic conditions like Down Syndrome
• Being older than 70+ 
• Children 
• People who have weak immunity
• People exposed to radiation, such as in a nuclear incident may experience its effects.
• People undergoing chemotherapy or radiation therapy may experience its effects.

What are the common symptoms related to abnormal ALL panel tests?

The symptoms of acute lymphoblastic leukemia might differ from person to person, but here are some common ALL symptoms include:

• Fatigue and dizziness
• Shortness of breath
• Bruising
• Fever or chills
• Palpitations
• Small and red spots on the skin
• Joint pain
• Loss of appetite
• Swelling around neck, underarm, abdomen
• Pale skin

What is the risk of Acute lymphoblastic leukemia (ALL) panel?

The ALL panel is a low-risk procedure, and no or minimal risk is associated with the ALL panel test. There are some aspects to consider regarding the risk of ALL panel tests.

• Slight pain or discomfort during sample collection.
• Some people may experience bruising or bleeding at the puncture site
• False-positive or false-negative results
• Hematoma 
• Risk of infection

ALL Panel Test price at Redcliffe Labs

The Acute Lymphoblastic Leukemia (ALL) Panel Price is INR 7900 at Redcliffe Labs. We offer the best diagnostic services. Our labs are NABL-accredited and ISO-certified to meet specific quality and safety standards. We offer a comprehensive range of tests, including the particular components of the ALL Panel Test. We assure you that we will provide accurate test reports on time. We adhere to strict policies and procedures to maintain patient privacy and confidentiality. Experience the fastest diagnostic experience by getting tested within 45 minutes. Book your Acute Lymphoblastic Leukemia (ALL) Panel test today!

Signifying the Relevance of the ALL Panel Test

ALL can arise when certain cells experience uncontrolled growth. The specific type of white blood cells affected and the genetic irregularities determine the classification of ALL. This form of cancer, recognized as acute lymphocytic leukemia, is not limited to childhood and can also impact adults. Take the Acute lymphoblastic leukemia panel from Redcliffe Labs and trust us for accurate test reports. Acute lymphoblastic leukemia has many treatment options. The treatment of ALL panel depends on the individual condition, age, disease progression, and subtype of leukemia. Consult your test reports with your healthcare provider to understand the treatment options and preventive methods.